SR-0813 is a potent and selective ENL/AF9 YEATS domain inhibitor. SR-0813 has IC50 and EC50 values of 25 nM and 205 nM for ENL YEATS domain, respectively. SR-0813 has IC50 and EC50 values of 311 nM and 76 nM (CETSA) for AF9 YEATS domain, respectively. SR-0813 binds MAP3K19 with over 100-fold lower affinity (Kd=3.5 μM) than ENL YEATS (Kd=30 nM). SR-0813 can be used for the research of acute leukemia[1].
SR-0813 is a potent and selective ENL/AF9 YEATS domain inhibitor. SR-0813 has IC50 values of 25 and 311 nM for ENL YEATS domain and AF9 YEATS domain, respectively.
ENL YEATS domain: 25 nM (IC50); ENL YEATS domain: 205 nM (EC50); AF9 YEATS domain: 311 nM (IC50); AF9 YEATS domain: 76 nM (EC50); ENL YEATS domain: 30 nM (Kd); MAP3K19: 3.5 μM (Kd)
[1] Garnar-Wortzel L, et al. ACS Cent Sci. 2021 May 26;7(5):815-830.